Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
US Food and Drug Administration Extends Review Timeline For BRILINTA (Ticagrelor) New Drug Application
-
European Commission Issues Positive Decision for Approval of Seroquel XR as an Add-On Treatment of Major Depressive Disorder
-
MedImmune receives complete response letter on motavizumab
-
Genetic substudy shows fewer major cardiovascular events with ticagrelor (brilinta) regardless of relevant genetic variability in ACS patients
-
AstraZeneca Announces Agreements in Principle in Seroquel Product Liability Litigation
-
FDA Advisory Committee recommends US FDA approval of Brilinta (ticagrelor) for Acute Coronary Syndromes
-
AstraZeneca Second Quarter and Half Year Results 2010
-
AstraZeneca PLC Appoints New Non-Executive Director
-
Advisory Committee Briefing Materials For Brilinta (Ticagrelor) NDA Available On US FDA Web Site
-
AstraZeneca and MRC Technology Form Strategic Alliance in Discovery Research, Utilising Shared Compound Libraries
Latest articles and press releases
All of our latest press releases and articles are available to explore
